Skip to main content

Table 2 Gene amplifications

From: Identification of functional pathways and molecular signatures in neuroendocrine neoplasms by multi-omics analysis

Gene

Samples (n)

Sample codes

Average fold change

RPS6KB1

12

1, 3, 5, 7, 8, 10, 11, 12, 15, 16, 55, 56

1.6

EGFR

9

2, 5, 8, 13, 15, 60, 61, 63, 65

1.6

BRAF

6

1, 5, 12, 13, 15, 61

1.5

ALK

4

5, 8, 10, 13

1.5

ERBB2

4

5, 12, 13, 55

1.9

FGF1

4

2, 4, 60, 61

1.6

FGFR1

4

2, 5, 13, 16

4.5

CCND3

3

2, 10, 16

1.5

CDK4

3

3, 61, 63

9.1

ERCC2

3

3, 5, 55

1.9

FGF10

3

3, 60, 61

1.7

FGF7

3

3, 15, 55

1.4

KIT

3

12, 13, 65

1.5

PDGFRA

3

5, 8, 12

1.5

RAF1

3

2, 5, 13

1.6

ERCC1

2

3, 5

2.0

FGF2

2

8, 12

1.5

LAMP1

2

5, 61

1.6

MET

2

13, 61

1.5

PDGFRB

2

60, 61

1.7

PIK3CA

2

5, 16

1.7

AR

1

3

1.5

BRCA2

1

2

1.4

CCND1

1

63

10.6

CDK6

1

61

1.6

ERBB3

1

63

2.8

FGF19

1

63

8.8

FGF23

1

3

1.5

FGF3

1

63

10.3

FGF4

1

63

10.3

FGFR2

1

5

2.1

FGFR4

1

61

1.9

JAK2

1

2

2.5

KRAS

1

3

1.4

MDM2

1

63

5.6

MDM4

1

15

1.5

MYC

1

3

26.5

MYCL

1

16

4.0

RICTOR

1

61

1.7

TFRC

1

5

3.1